SCHEMBL6963327

SCHEMBL6963327

[O]Cc1ccc2[nH]ccc2c1

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
AHR P35869 3/20 0.50
CYP2A6 P11509 2/20 0.50
NR4A2 P43354 2/20 0.50
F7 P08709 1/20 0.50
LTA4H P09960 1/20 0.50
F3 P13726 1/20 0.50
USP2 O75604 1/20 0.50
GAA P10253 1/20 0.50
ALOX15 P16050 1/20 0.50
RAD51 Q06609 1/20 0.50
NPSR1 Q6W5P4 1/20 0.50
HDAC1 Q13547 1/20 0.49
HDAC8 Q9BY41 1/20 0.49
CYP17A1 P05093 1/20 0.47
CYP11B1 P15538 1/20 0.47
CYP11B2 P19099 1/20 0.47
IMPDH2 P12268 1/20 0.46
IMPDH1 P20839 1/20 0.46
NPC1 O15118 1/20 0.46
CTNNB1 P35222 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL28311634 0.83 AHR (0.50) AHRCYP2A6MAOACA1CA2
SCHEMBL17613377 0.83 AHR (0.50) AHRCYP2A6NR4A2F7LTA4H
SCHEMBL8666600 0.83 HDAC1 (0.55) AHRCYP2A6NR4A2F7LTA4H
SCHEMBL28755927 0.80 CYP2A6 (0.56) AHRCYP2A6NR4A2F7LTA4H
SCHEMBL5057022 0.79 AHR (0.50) AHRCYP2A6NR4A2F7LTA4H
SCHEMBL951685 0.79 USP2 (0.55) AHRCYP2A6NR4A2F7LTA4H
SCHEMBL30614296 0.79 USP2 (0.55) AHRCYP2A6NR4A2F7LTA4H
SCHEMBL6582346 0.79 AHR (0.55) AHRCYP2A6NR4A2F7LTA4H
SCHEMBL29361377 0.79 AHR (0.50) AHRCYP2A6NR4A2F7LTA4H
SCHEMBL763201 0.79 AHR (0.50) AHRCYP2A6NR4A2F7LTA4H

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6642255-B2 Substituted carbocyclic or heterocyclic hydroxamic acid derivatives, e.g., (3R,4S)-N-hydroxy-1-methyl-3-(((4-((2-methyl-4 -quinolinyl)methoxylphenyl)sulfonyl)methyl)-4-piperidinecarboxamide BRISTOL-MYERS SQUIBB PHARMA COMPANY 2003-11-04 US disclosed
EP-1355648-A2 1,2-DISUBSTITUTED CYCLIC INHIBITORS OF MATRIX METALLORPROTEASES AND TNF-$g(a) Bristol-Myers Squibb Pharma Company (US) 2003-10-29 EP disclosed
WO-2002055491-A2 1,2-DISUBSTITUTED CYCLIC INHIBITORS OF MATRIX METALLORPROTEASES AND TNF-$g(a) BRISTOL MYERS SQUIBB COMPANY P (US) 2002-07-18 WO disclosed